Morningstar Investment Services’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $243K | Sell |
1,158
-147
| -11% | -$28.6K | 0.04% | 132 |
|
|
2024
Q4 | $232K | Sell |
1,305
-8,569
| -87% | -$1.58M | 0.02% | 138 |
|
|
2024
Q3 | $1.92M | Buy |
9,874
+1,709
| +21% | +$319K | 0.02% | 175 |
|
|
2024
Q2 | $1.38M | Buy |
8,165
+1,140
| +16% | +$189K | 0.02% | 183 |
|
|
2024
Q1 | $1.27M | Sell |
7,025
-3,669
| -34% | -$632K | 0.01% | 177 |
|
|
2023
Q4 | $1.66M | Buy |
10,694
+5,616
| +111% | +$819K | 0.01% | 196 |
|
|
2023
Q3 | $773K | Buy |
5,078
+2,236
| +79% | +$328K | 0.01% | 189 |
|
|
2023
Q2 | $378K | Buy |
2,842
+648
| +30% | +$95K | ﹤0.01% | 206 |
|
|
2023
Q1 | $347K | Buy |
2,194
+291
| +15% | +$44.5K | ﹤0.01% | 197 |
|
|
2022
Q4 | $306K | Hold |
1,903
| – | – | ﹤0.01% | 197 |
|
|
2022
Q3 | $285K | Buy |
1,903
+57
| +3% | +$8.18K | ﹤0.01% | 197 |
|
|
2022
Q2 | $284K | Sell |
1,846
-39,823
| -96% | -$6.09M | ﹤0.01% | 198 |
|
|
2022
Q1 | $6.8M | Buy |
41,669
+3,184
| +8% | +$463K | 0.08% | 130 |
|
|
2021
Q4 | $5.21M | Buy |
38,485
+1,724
| +5% | +$204K | 0.06% | 135 |
|
|
2021
Q3 | $3.99M | Buy |
36,761
+802
| +2% | +$91.6K | 0.05% | 136 |
|
|
2021
Q2 | $4.04M | Buy |
35,959
+1,365
| +4% | +$154K | 0.05% | 134 |
|
|
2021
Q1 | $3.69M | Sell |
34,594
-138
| -0.4% | -$14.8K | 0.05% | 153 |
|
|
2020
Q4 | $3.72M | Sell |
34,732
-5,400
| -13% | -$519K | 0.05% | 155 |
|
|
2020
Q3 | $3.49M | Sell |
40,132
-1,900
| -5% | -$179K | 0.05% | 149 |
|
|
2020
Q2 | $4.05M | Buy |
42,032
+37,532
| +834% | +$3.3M | 0.07% | 144 |
|
|
2020
Q1 | $339K | Buy |
+4,500
| New | +$383K | 0.01% | 172 |
|
|
2018
Q3 | – | Sell |
-2,479
| Closed | -$230K | – | 201 |
|
|
2018
Q2 | $230K | Hold |
2,479
| – | – | ﹤0.01% | 196 |
|
|
2018
Q1 | $235K | Sell |
2,479
-115
| -4% | -$12.6K | ﹤0.01% | 193 |
|
|
2017
Q4 | $251K | Sell |
2,594
-536
| -17% | -$50.5K | 0.01% | 189 |
|
|
2017
Q3 | $278K | Buy |
+3,130
| New | +$238K | 0.01% | 178 |
|
|
2015
Q1 | – | Sell |
-10,066
| Closed | -$659K | – | 207 |
|
|
2014
Q4 | $659K | Buy |
10,066
+1,600
| +19% | +$101K | 0.03% | 169 |
|
|
2014
Q3 | $489K | Buy |
8,466
+124
| +1% | +$6.88K | 0.03% | 180 |
|
|
2014
Q2 | $471K | Buy |
+8,342
| New | +$438K | 0.03% | 167 |
|
|
2014
Q1 | – | Sell |
-3,785
| Closed | -$200K | – | 198 |
|
|
2013
Q4 | $200K | Buy |
+3,785
| New | +$186K | 0.02% | 197 |
|
Other funds holding ABBV
Morningstar Investment Services's ABBV Position: Q1 2025 in Review
Morningstar Investment Services reduced its AbbVie (ABBV) stake by 11% in Q1 2025, selling an estimated $28.6K and leaving 1,158 shares worth $243K. The position accounts for 0.04% of the portfolio, ranked #132.
Morningstar Investment Services first reported a position in ABBV in Q4 2013 and has held it in 29 quarters since. The position peaked at $6.8M in Q1 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.
- Morningstar Investment Services held 1,158 shares of AbbVie worth $243K as of Q1 2025.
- Morningstar Investment Services sold 147 AbbVie shares in Q1 2025, an estimated $28.6K.
- AbbVie made up 0.04% of Morningstar Investment Services's portfolio in Q1 2025, its #132 holding.
- Morningstar Investment Services first reported a position in AbbVie in Q4 2013 and has held it in 29 quarters since.
- Morningstar Investment Services's AbbVie position peaked at $6.8M in Q1 2022.
- 3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.
Based on Morningstar Investment Services's 13F filing for Q1 2025, filed 5 May 2025.